CTOs on the Move

University of Maryland Medical System

www.umms.org

 
The University of Maryland Medical System (UMMS) is a university-based regional health care system focused on serving the health care needs of Maryland. We bring innovation, discovery and research to the care we provide all while educating the state`s future physicians and health care professionals through our partnership with the University of Maryland School of Medicine and the UM Schools of Nursing, Pharmacy, Social Work and Dentistry in Baltimore. As one of the largest private employers in the state, the health system`s 25,000 employees and 4,000 affiliated physicians provide primary and specialty care in more than 150 locations and at 13 hospitals. UMMS` ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.umms.org
  • 250 W. Pratt Street
    Baltimore, MD USA 21201
  • Phone: 410.328.2450

Executives

Name Title Contact Details

Similar Companies

Rayant

Rayant is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthLinx Executive Search

HealthLinx Executive Search is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AmeriBest Home Care

AmeriBest Home Care is a home healthcare agency that provides high quality comprehensive home health and personal care services to patients in the Philadelphia and Harrisburg, PA areas.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

Convaquip Industries Inc

Convaquip Industries Inc is a Abilene, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.